Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P.
Frazier Life Sciences Public Fund, L.P., filed by
ACRS
Aclaris Therapeutics, Inc. SEC filings
Every EDGAR filing for Aclaris Therapeutics, Inc. (ACRS), newest first, with AI summaries and stories.
- Ticker
- ACRS
- CIK
- 1557746
- Latest filing
- Sep 21
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 16)
Filings
SCHEDULE 13GAclaris Therapeutics, Inc.ACRSLIVE SCHEDULE 13G/AAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)
RA CAPITAL MANAGEMENT, L.P., filed by
8-KAclaris Therapeutics, Inc.ACRSLIVE S-3ASRAclaris Therapeutics, Inc.ACRSLIVE 10-QAclaris Therapeutics, Inc.ACRSLIVE 8-KAclaris Therapeutics, Inc.ACRSLIVE 4Aclaris Therapeutics, Inc.ACRSLIVE Roland Wilhelm Kolbeck, insider filing for ACRS
Roland Wilhelm Kolbeck, reporting
4Aclaris Therapeutics, Inc.ACRSLIVE 6 insider filings
Vincent Milano, insider filing for ACRS
Show all 6
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
Vincent Milano, reporting
8-KAclaris Therapeutics, Inc.ACRSLIVE SCHEDULE 13G/AAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by Vivo Opportunity Fund Holdings, L.P. (amended)
Vivo Opportunity Fund Holdings, L.P., filed by
10-QAclaris Therapeutics, Inc.ACRSLIVE 8-KAclaris Therapeutics, Inc.ACRSLIVE 4Aclaris Therapeutics, Inc.ACRSLIVE Jesse Wayne Hall, insider filing for ACRS
Jesse Wayne Hall, reporting
8-KAclaris Therapeutics, Inc.ACRSLIVE 4Aclaris Therapeutics, Inc.ACRSLIVE Braden Michael Leonard, insider filing for ACRS
Braden Michael Leonard, reporting
SCHEDULE 13G/AAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by BML Investment Partners, L.P. (amended)
BML Investment Partners, L.P., filed by
ARSAclaris Therapeutics, Inc.ACRSLIVE DEFA14AAclaris Therapeutics, Inc.ACRSLIVE DEF 14AAclaris Therapeutics, Inc.ACRSLIVE SCHEDULE 13GAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P., filed by
SCHEDULE 13G/AAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
SCHEDULE 13GAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by Deep Track Capital, LP
Deep Track Capital, LP, filed by
8-KAclaris Therapeutics, Inc.ACRSLIVE 8-KAclaris Therapeutics, Inc.ACRSLIVE 4Aclaris Therapeutics, Inc.ACRSLIVE Kevin Balthaser, insider filing for ACRS
Kevin Balthaser, reporting
10-KAclaris Therapeutics, Inc.ACRSLIVE 8-KAclaris Therapeutics, Inc.ACRSLIVE SCHEDULE 13G/AAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by BML Investment Partners, L.P. (amended)
BML Investment Partners, L.P., filed by
4Aclaris Therapeutics, Inc.ACRSLIVE 6 insider filings
Neal Walker, insider filing for ACRS
Show all 6
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
Neal Walker, reporting
4Aclaris Therapeutics, Inc.ACRSLIVE 5 insider filings
James Loerop, insider filing for ACRS
Show all 5
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4/AInsider filing for ACRS (amended)
James Loerop, reporting
4Aclaris Therapeutics, Inc.ACRSLIVE 3 insider filings
Kevin Balthaser, insider filing for ACRS
Show all 3
- 4Insider filing for ACRS
- 4Insider filing for ACRS
- 4/AInsider filing for ACRS (amended)
Kevin Balthaser, reporting
SCHEDULE 13G/AAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
8-KAclaris Therapeutics, Inc.ACRSLIVE SCHEDULE 13G/AAclaris Therapeutics, Inc.ACRSLIVE Ownership stake disclosure by Bonita Biotech (HK) Ltd (amended)
Bonita Biotech (HK) Ltd, filed by